Neutralization of Infectivity of Diverse R5 Clinical Isolates of Human Immunodeficiency Virus Type 1 by gp120-Binding 2′F-RNA Aptamers

Journal of Virology

Volumn 77, Issue 23, 2003, Pages 12692-12698

  Khati, Makobetsa ^a   Schüman, Michael ^a   Ibrahim, Jamal ^a   Sattentau, Quentin ^b   Gordon, Siamon ^a   James, William ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2' FLUOROPYRIMIDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIRETROVIRUS AGENT; APTAMER; CD4 ANTIGEN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; EPITOPE; FLUOROPYRIMIDINE; GLYCOPROTEIN GP 120; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; NUCLEIC ACID; UNCLASSIFIED DRUG; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; BINDING AFFINITY; BINDING SITE; CELLULAR IMMUNITY; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMORAL IMMUNITY; MONONUCLEAR CELL; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN RNA BINDING; VIRUS CELL INTERACTION; VIRUS INFECTIVITY; VIRUS ISOLATION; VIRUS NEUTRALIZATION; VIRUS STRAIN; VIRUS TRANSMISSION;

BASE SEQUENCE; CELLS, CULTURED; DNA PRIMERS; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; RNA, VIRAL;

EID: 0242409220     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.23.12692-12698.2003     Document Type: Article

References (52)

1. Arendrup, M., C. Nielsen, et al. 1992. Autologous HIV-1 neutralizing antibodies: emergence of neutralization-resistant escape virus and subsequent development of escape virus neutralizing antibodies. J. Acquir. Immune Defic. Syndr. 5:303-307.
2. Barre-Sinoussi, F., J. C. Chermann, et al. 1983. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220:868-871.
3. Bewley, C. A., J. M. Louis, et al. 2002. Design of a novel peptide inhibitor of HIV fusion that disrupts the internal trimeric coiled-coil of gp41. J. Biol. Chem. 277:14238-14245.
4. Bosworth, N., and P. Towers. 1989. Scintillation proximity assay. Nature 341:167-168.
5. Buchacher, A., R. Predl, et al. 1994. Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization. AIDS Res. Hum. Retrovir. 10:359-369.
6. Burton, D. R., C. F. Barbas III, et al. 1991. A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. Proc. Natl. Acad. Sci. USA 88:10134-10137.
7. Chan, D. C., C. T. Chutkowski, et al. 1998. Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target. Proc. Natl. Acad. Sci. USA 95:15613-15617.
8. Chavda, S. C., P. Griffin, et al. 1994. Molecular determinants of the V3 loop of human immunodeficiency virus type 1 glycoprotein gp120 responsible for controlling cell tropism. J. Gen. Virol. 75:3249-3253.
9. Chesebro, B., J. Nishio, et al. 1991. Identification of human immunodeficiency virus envelope gene sequences influencing viral entry into CD4-positive HeLa cells, T-leukemia cells, and macrophages. J. Virol. 65:5782-5789.
10. Collin, M., G. Herbein, et al. 1993. PCR analysis of HIV1 infection of macrophages: virus entry is CD4-dependent. Res. Virol. 144:13-19.
11. Collin, M., P. Illei, et al. 1994. Definition of the range and distribution of HIV macrophage tropism using PCR-based infectivity measurements. J. Gen. Virol. 75:1597-1603.
12. Cordonnier, A., L. Montagnier, et al. 1989. Single amino-acid changes in HIV envelope affect viral tropism and receptor binding. Nature 340:571-574.
13. Ellington, A. D., and J. W. Szostak. 1990. In vitro selection of RNA molecules that bind specific ligands. Nature 346:818-822.
14. Ferrer, M., T. M. Kapoor, et al. 1999. Selection of gp41-mediated HIV-1 cell entry inhibitors from biased combinatorial libraries of non-natural binding elements. Nat. Struct. Biol. 6:953-960.
15. + T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat. Med. 5:512-517.
16. Fitzwater, T., and B. Polisky. 1996. A SELEX primer. Methods Enzymol. 267:275-301.
17. Gartner, S., P. Markovits, et al. 1986. Virus isolation from and identification of HTLV-III/LAV-producing cells in brain tissue from a patient with AIDS. JAMA 256:2365-2371.
18. Gendelman, H. E., J. M. Orenstein, et al. 1989. The macrophage in the persistence and pathogenesis of HIV infection. AIDS 3:475-495.
19. Gendelman, H. E., J. M. Orenstein, et al. 1988. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J. Exp. Med. 167:1428-1441.
20. Gershoni, J. M., G. Denisova, et al. 1993. HIV binding to its receptor creates specific epitopes for the CD4/gp120 complex. FASEB J. 7:1185-1187.
21. Karlsson, R., A. Michaelsson, et al. 1991. Kinetic analysis of monoclonal antibody-antigen interactions with a new biosensor based analytical system. J. Immunol. Methods 145:229-240.
22. Kilby, J. M., S. Hopkins, et al. 1998. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nat. Med. 4:1302-1307.
23. King, L., and R. Possee. 1992. The baculovirus expression system: a laboratory guide. Chapman & Hall, London, United Kingdom.
24. Kowalski, M., J. Potz, et al. 1987. Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. Science 237:1351-1355.
25. + T lymphocyte function. J. Immunol. 160:5209-5212.
26. Kwong, P. D., R. Wyatt, et al. 2000. Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates. Struct. Fold Des. 8:1329-1339.
27. Kwong, P. D., R. Wyatt, et al. 1998. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393:648-659.
28. Lin, C. L., A. K. Sewell, et al. 2000. Macrophage-tropic HIV induces and exploits dendritic cell chemotaxis. J. Exp. Med. 192:587-594.
29. McKeating, J. A., J. Gow, et al. 1989. Characterization of HIV-1 neutralization escape mutants. AIDS 3:777-784.
30. Mondor, I., M. Moulard, et al. 1998. Interactions among HIV gp120, CD4, and CXCR4: dependence on CD4 expression level, gp120 viral origin, conservation of the gp120 COOH- and NH2-termini and V1/V2 and V3 loops, and sensitivity to neutralizing antibodies. Virology 248:394-405.
31. Moore, J. P. and D. D. Ho. 1995. HIV-1 neutralization: the consequences of viral adaptation to growth on transformed T cells. AIDS 9(Suppl. A):S117-S136.
32. Moore, J. P., J. A. McKeating, et al. 1990. Characterization of recombinant gp120 and gp160 from HIV-1: binding to monoclonal antibodies and soluble CD4. AIDS 4:307-315.
33. Mosier, D., and H. Sieburg. 1994. Macrophage-tropic HIV: critical for AIDS pathogenesis? Immunol. Today 15:332-339.
34. Pagratis, N. C., C. Bell, et al. 1997. Potent 2′-amino-, and 2′-fluoro-2′-deoxyribonucleotide RNA inhibitors of keratinocyte growth factor. Nat. Biotechnol. 15:68-73.
35. Pilgrim, A. K., G. Pantaleo, et al. 1997. Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection. J. Infect. Dis. 176:924-932.
36. Ping, L. H., J. A. Nelson, et al. 1999. Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants. J. Virol. 73:6271-6281.
37. Piot, P., M. Bartos, et al. 2001. The global impact of HIV/AIDS. Nature 410:968-973.
38. Prince, A. M., H. Reesink, et al. 1991. Prevention of HIV infection by passive immunization with HIV immunoglobulin. AIDS Res. Hum. Retrovir. 7:971-973.
39. Rizzuto, C., and J. Sodroski. 2000. Fine definition of a conserved CCR5-binding region on the human immunodeficiency virus type 1 glycoprotein 120. AIDS Res. Hum. Retrovir. 16:741-749.
40. Rizzuto, C. D., R. Wyatt, et al. 1998. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science 280:1949-1953.
41. Samson, M., F. Libert, et al. 1996. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382:722-725.
42. Sayer, N., J. Ibrahim, et al. 2002. Structural characterization of a 2′ F-RNA aptamer that binds HIV-1 SU glycoprotein, gp120. Biochem. Biophys. Res. Commun. 293:924-931.
43. Simon, J. H., C. Somoza, et al. 1993. A rat CD4 mutant containing the gp120-binding site mediates human immunodeficiency virus type 1 infection. J. Exp. Med. 177:949-954.
44. Sullivan, N., Y. Sun, et al. 1998. CD4-induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: consequences for virus entry and neutralization. J. Virol. 72:4694-4703.
45. Tahiri-Alaoui, A., L. Frigotto, et al. 2002. High affinity nucleic acid aptamers for streptavidin incorporated into bi-specific capture ligands. Nucleic Acids Res. 30:1-9.
46. Thali, M., J. P. Moore, et al. 1993. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding. J. Virol. 67:3978-3988.
47. Trkola, A., S. E. Kuhmann, et al. 2002. HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use. Proc. Natl. Acad. Sci. USA 99:395-400.
48. Warrier, S. V., A. Pinter, et al. 1994. A novel, glycan-dependent epitope in the V2 domain of human immunodeficiency virus type 1 gp120 is recognized by a highly potent, neutralizing chimpanzee monoclonal antibody. J. Virol. 68:4636-4642.
49. Wei, X., J. Decker, et al. 2003. Antibody neutralization and escape by HIV-1. Nature 422:307-312.
50. Wu, L., N. P. Gerard, et al. 1996. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 384:179-183.
51. Wyatt, R., J. Moore, et al. 1995. Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding. J. Virol. 69:5723-5733.
52. Zollner, B., H. H. Feucht, et al. 2001. Primary genotypic resistance of HIV-1 to the fusion inhibitor T-20 in long-term infected patients. AIDS 15:935-936.